Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Diagnostic proficiency and reporting of Lassa fever by physicians in Osun State of Nigeria

  • Samuel Anu Olowookere1Email author,
  • Akinola Ayoola Fatiregun2,
  • Olalere Omoyosola Gbolahan3 and
  • Ebenezer Gbenga Adepoju4
BMC Infectious Diseases201414:344

DOI: 10.1186/1471-2334-14-344

Received: 2 January 2014

Accepted: 17 June 2014

Published: 20 June 2014

Abstract

Background

Lassa fever is highly contagious and commonly results in death. It is therefore necessary to diagnose and report any suspected case of Lassa fever to facilitate preventive strategies. This study assessed the preparedness of physicians in the diagnosis and reporting of Lassa fever.

Methods

The study design was descriptive cross-sectional. The consenting medical doctors completed a self-administered questionnaire on the diagnosis and reporting of Lassa fever. Descriptive and inferential statistics were used in data analyses.

Results

One hundred seventy-five physicians participated in the study. The mean age was 41.5 ± 10.9 years (range, 24–75 years). Most of the physicians were male (78.9%) and had practiced medicine ≥ 20 years (51.5%). Most of the physicians had a good knowledge regarding the diagnosis and reporting of Lassa fever; however, none of the physicians had ever diagnosed or reported a suspected case. Predictors of good knowledge include male sex, not practicing at a secondary health care level and post graduation year more than 20 years.

Conclusion

There is disparity in knowledge and practices of physicians regarding the diagnosis and reporting of Lassa fever. Thus, it is necessary to improve the knowledge and practices of physicians regarding the diagnosis and reporting of Lassa fever.

Keywords

Assessment Diagnosis Reporting Lassa fever Nigerian physicians

Background

Lassa fever is a viral haemorrhagic fever caused by a rodent-borne arenavirus that is endemic to West Africa [13]. Arenaviruses are emerging in the African continent and can cause haemorrhagic fevers with case fatalities between 10% and 20% [4, 5]. These viruses are mainly transmitted through contact with the excreta of the natural host (rodents of the family Muridae) [68]. The Old World arenavirus, Lassa virus, causes up to 300,000 cases of Lassa fever annually in West Africa [911]. In the 1970s the rodent host of Lassa virus was classified as Mastomys natalensis. Other rodent hosts, such as M. erythroleucus, and the Rattus and Mus genera, have been suggested [1214]. Health care workers are predominantly infected and likely to die from Lassa fever in the central and southern parts of Nigeria, most often due to poor medical practices, late diagnosis, and treatment [10, 15]. The establishment of diagnostic facilities that can provide rapid molecular testing at referral centers in the disease-endemic zones has been suggested as a partial solution to this problem. This testing would facilitate appropriate case and contact management, including early treatment and post-exposure prophylaxis with Ribavirin, and eventually raise awareness that Lassa fever should be considered in every severe febrile illness in these regions of Nigeria and West Africa [14, 16].

Although no previous cases of Lassa fever has been reported in the State of Osun in Nigeria, outbreaks of the disease were reported in several states of Nigeria including nearby Edo state.

In the first quarter of 2012, 623 suspected cases, including 70 deaths were recorded from 19 of the 36 States of Nigeria. Laboratory analysis undertaken at the Irrua Specialist Teaching Hospital, Irrua Edo State, Nigeria confirmed the presence of Lassa virus infection in 108 patients. Three doctors and four nurses were among the fatalities [17].

Since medical doctors are the first point of contact in diagnosing and reporting cases of Lassa fever, it is imperative to conduct baseline studies to assess the diagnostic knowledge and reporting of Lassa fever among physicians in Nigeria, hence the need for this study.

This study determined the preparedness of physicians in the diagnosis and reporting of Lassa fever.

Methods

Study setting

Osun state is one of 36 states in Nigeria, and is located in the southwestern part of Nigeria. Osun state is bounded on the north by Kwara state, on the east by Ekiti and Ondo states, on the south by Ogun state, and on the west by Oyo state. Osun state has 30 local government areas with several maternity centres, comprehensive health centres, and state hospitals spread across the state. Also, LAUTECH Teaching Hospital, Osogbo and Obafemi Awolowo University Teaching Hospital Complex, Ile-Ife are situated in Osun state. As at the time this study was conducted, about 600 medical doctors practice medicine in Osun state.

Study design

This was a descriptive cross-sectional study conducted in the month of June, 2013. All physicians attending a Nigerian Medical Association (NMA)-organized Continuing Medical Education programme at the NMA house in Osogbo, which is a requirement for annual licensure, were approached, after taken their consent.

Data collection

A validated (face validity) semi-structured, self-administered questionnaire was used to obtain data on the respondents sociodemographic characteristics, knowledge, diagnosis, management and reporting of Lassa fever.

Data analysis

The data obtained were entered into SPSS version 16 and analyzed as frequencies for categorical variables, and mean and standard deviation for continuous variables. Knowledge score was computed for a 19-item question on general knowledge of Lassa fever. Each item was assigned ‘+1’ for correct knowledge and ‘0’ for incorrect knowledge. The knowledge score was graded as good or appropriate (if respondent scored ≥ 10 points), and not good or not appropriate (if score was < 10 points). Knowledge score was also computed for a 10-item question on Lassa fever management and reporting. Each item was assigned ‘+1’ for correct knowledge and ‘0’ for incorrect knowledge. The score was classified into good or appropriate (if respondent scored > 5 points) and not good or not appropriate (≤5 points). Bivariate chi-square test and multivariate logistic analyses were performed on respondent’s characteristics and general knowledge on Lassa fever, as well as knowledge on management and reporting. Variables in the bivariate test with p-value of <0.2 were included in the multi-variate model. A p value <0.05 was accepted as significant.

Ethical clearance

Permission to conduct the study was sought from the Osun state branch of the Nigerian Medical Association, while verbal consent was obtained from every medical doctor approached to participate in the study. Permission to conduct the study was granted by the State Hospital Ethics and Research Committee (protocol no: SHO/ERC/13/007). The data collected was entered and kept in a password-protected computer.

Results

Characteristics of respondents

Out of 192 physicians, 5 declined participation while 9 did not return their questionnaire. Three questionnaires were excluded from analysis because of non-completeness. One hundred seventy-five questionnaires with completed data were analysed. The mean age of the study participants was 41.5 ± 10.9 years, majority (78.9%) of them were males, 83.4% were married, while a larger proportion (92.6%) were of Yoruba tribe. More than half (51.5%) of the study participants had a post University graduation of more than 20 years to the time of the data collection, 47.3% ranged between 10 to 20 years and only 1.2% had graduated less than 10 years ago (Table 1). About 44.9% of the participants had more than five years of post residency training. The mean number of years of participant’s clinical practice in primary, secondary and tertiary health care was 6.3, 8.8, and 6.5 years respectively.
Table 1

Respondent’s characteristics

Variable

Frequency (n)

Percentage (%)

Age:

  

20–24 years

2

1.4

25–29 years

18

12.2

30–34 years

26

17.6

35–39 years

30

20.3

≥ 40 years

72

48.6

Gender:

  

Male

138

78.9

Female

37

21.1

Ethnicity:

  

Yoruba

162

92.6

Igbo

8

4.6

Other

5

2.9

Year of graduation:

  

More than 20 years

85

51.5

10–20 years

78

47.3

Less than 20 years

2

1.2

Years of post residency:

  

≤ 5 years

27

55.1

> 5 years

22

44.9

Primary clinical practice:

  

Yes

70

40

No

105

60

Secondary clinical practice:

  

Yes

111

63.4

No

64

36.6

Tertiary clinical practice:

  

Yes

99

56.6

No

76

43.4

Designation:

  

Consultant

33

18.9

Medical officer

29

16.6

Other

22

12.6

Senior medical officer

21

12.0

Registrar

19

10.9

Chief medical officer

20

11.4

Senior registrar

14

8.0

House officer

10

5.7

Principal medical officer

7

4.0

Department:

  

A & E

3

2.4

Anesthesia

3

2.4

Biochemistry

2

1.6

Dental health

16

12.8

Community health

11

8.8

ENT

2

1.6

Family medicine

7

5.6

GOPD

28

22.4

Health centre

9

7.2

Internal medicine

3

2.4

Anatomy

1

0.8

O & G

6

4.8

Ophthalmology

3

2.4

Oral path/OMS

3

2.4

Orthopaedics

1

0.8

Pediatrics

4

3.2

Private practice

3

2.4

Psychiatry

1

0.8

Radiology

1

0.8

Surgery

17

13.6

Hospital board

1

0.8

About 18.9% of the respondents were consultants, only 16.6% were medical officers, and the rest are shown in Table 1. Some physicians worked in primary care such as General out-patient department (GOPD) (22.4%), Family medicine (5.6%), Community Health (8.8%), Health centre (7.2%) and private practice (2.4%).

Lassa fever knowledge

Figure 1 shows that more than half (62%) of the respondents had good general knowledge on Lassa fever. As shown in Table 2, majority (93.1%) of the respondents knew that Lassa fever is a viral infection, 57.1% agreed that the incubation period ranges from 1 – 3 weeks, and 85.2% agreed the infection can be characterized by fever > 38°C. Majority (82.9%) of the respondents reported that cases can not be confirmed without laboratory diagnosis, and 98.2% of them disagreed to ‘pediatrics clients being excluded from diagnoses’. Only 34.8% of the respondents agreed that aerosol transmission of the infection is possible, while 43.0% reported semen of case being capable of transmitting infection.
https://static-content.springer.com/image/art%3A10.1186%2F1471-2334-14-344/MediaObjects/12879_2014_Article_3698_Fig1_HTML.jpg
Figure 1

Graded score on Lassa fever knowledge.

Table 2

Lassa fever knowledge

Variable

Frequency (n)

Percentage (%)

Lassa fever is a viral disease:

  

Yes

163

93.1

No

5

2.9

Incubation period ranges for 1–3 weeks:

  

Yes

100

57.1

No

64

36.6

Reservoir – rat:

  

Yes

169

96.6

No

3

1.7

Transmitted by rat biting:

  

Yes

34

19.4

No

131

74.9

Cases are characterized by fever >38°C:

  

Yes

144

85.2

No

25

14.8

Retrosternal pain is a common symptom:

  

Yes

66

41.5

No

93

58.5

Bleeding from mucosal surface is a sign:

  

Yes

142

84.5

No

26

15.5

Vomiting and shock is rarely observed:

  

Yes

43

25.3

No

127

74.7

Proteinuria is suggestive:

  

Yes

44

27.2

No

127

72.8

Fever refractory to treat and mucosal bleeding is a sign:

  

Yes

134

79.3

No

35

20.7

Absence of profuse mucosal bleeding exclude diagnosis:

  

Yes

5

3

No

161

97

Pediatrics clients are excluded from diagnosis:

  

Yes

3

1.8

No

164

98.2

Cases can be confirmed without lab diagnosis:

  

Yes

28

17.1

No

136

82.9

Aerosol transmission:

  

Yes

57

34.8

No

107

65.2

Causative organism penetrates unbroken skin:

  

Yes

37

22.8

No

125

77.2

Cases cease to be infectious after acute phase:

  

Yes

18

11.0

No

146

89.0

Semen of case is capable of transmitting infection:

  

Yes

71

43.0

No

94

57.0

Jaundice is a common manifestation:

  

Yes

103

62.4

No

62

37.6

Bodies of dead cases constitute potential harm:

  

Yes

122

73.1

No

45

26.9

Knowledge on Lassa fever treatment

Table 3 shows the response of the participants to knowledge of Lassa fever treatment. Ribavirin was reported by 80.6% of the respondents as the drug used for treatment of Lassa fever, other drugs listed were Corticosteroid (5.6%), Ranitidine (5.6%), and antiviral drug (8.2%). Majority (61.2%) of the respondents reported absence of bleeding to be a good prognostic sign during Lassa fever treatment.
Table 3

Treatment agent

Variable

Frequency (n)

Percentage (%)

Drug used for treatment:

  

Ribavirin

29

80.6

Corticosteroid

2

5.6

Ranitidine

2

5.6

Antiviral drug

3

8.2

Patients nursed in open wards:

  

Yes

7

4.5

No

133

84.7

Not sure

17

10.8

Corticosteroids important in management:

  

Yes

53

34.2

No

31

20.0

Not sure

71

45.8

Absence of bleeding good prognostic sign:

  

Yes

98

61.2

No

16

10.0

Not sure

46

28.8

Knowledge on Lassa fever reporting

Few (19.4%) of the respondents agreed that a critical number of cases must be observed before reporting, while 80.6% did not agree to that. Most (82.5%) of the participants agreed that suspected cases qualify for reporting, while 73% agreed that confirmed cases can be reported. More than half (61.1%) of the respondents reported that it is not true that cases should be reported weekly for administrative efficiency (Table 4).
Table 4

Knowledge on Lassa fever reporting

Variable

Frequency (n)

Percentage (%)

Critical minimum number of cases must be observed before reporting:

  

True

30

19.4

Not true

125

80.6

Suspected case:

  

True

138

82.5

Not true

28

17.5

Confirmed case:

  

True

43

27

Not true

116

73

Weekly reporting:

  

True

58

38.9

Not true

91

61.1

Federal:

  

True

79

50

Not true

79

50

State:

  

True

83

52.5

Not true

75

47.5

Local:

  

True

67

43.8

Not true

86

56.2

Respondent’s characteristics and Lassa fever knowledge

Table 5 shows the association of respondent’s characteristics with knowledge of Lassa fever. A higher proportion (77.3%) of the respondents who were older than 40 years had an appropriate knowledge on Lassa fever, compared to 21.9% of those who were younger than 40 years, although this was not significant (p = 1.000). Surprisingly, a significantly higher proportion (35.8%) of the respondents who did not have clinical practice in a secondary health facility had an appropriate knowledge on Lassa fever, compared to 19.8% of those who were had practiced in a secondary health facility (p = 0.049).
Table 5

Association between respondent’s characteristics and Lassa fever knowledge

 

Knowledge

  

Variable

Appropriate

Not appropriate

χ2

P-value

Age:

    

< 40 years

14 (21.9)

50 (78.1)

  

≥ 40 years

51 (77.3)

15 (22.7)

0.907

1.000

Gender:

    

Male

31 (25.8)

89 (74.2)

  

Female

22 (75.9)

7 (24.1)

0.851

1.000

Ethnicity:

    

Yoruba

34 (24.6)

104 (75.4)

  

Igbo

3 (37.5)

5 (62.5)

  

Other

1 (33.3)

2 (66.7)

0.757

0.685

Marital status:

    

Currently married

34 (26.6)

94 (73.4)

  

Currently not married

4 (19.0)

17 (81.0)

0.414

0.594

Years of graduation:

    

More than 20 years

20 (26.7)

55 (73.3)

  

10–20 years

16 (23.2)

53 (76.8)

0.865

0.471

Less than 10 years

    

Years of residency:

    

≤ 5 years

6 (27.3)

16 (72.7)

  

> 5 years

5 (25.0)

15 (75.0)

0.867

1.000

Primary health care

    

practice: Yes

13 (20)

52 (80)

  

No

25 (29.8)

59 (70.2)

0.175

0.190

Secondary health care

    

practice: Yes

19 (19.8)

77 (80.2)

  

No

19 (35.8)

34 (64.2)

0.031

0.049

Tertiary health care

    

practice: Yes

23 (26.7)

63 (73.3)

  

No

15 (23.8)

48 (76.2)

0.685

0.708

Predictors of knowledge on Lassa fever

Table 6 shows the result of the multivariable model. Respondents who were not practicing at a secondary health care level were more likely to have an appropriate knowledge on Lassa fever (OR = 0.41, 95% CI = 0.192–0.889).
Table 6

Logistic regression for respondent’s characteristics and Lassa fever knowledge

Variable

OR

95% CI

P-value

Primary health care practice

0.54

0.245–1.180

0.122

Secondary health care practice

0.41

0.192–0.889

0.024

Association between respondent’s characteristics and knowledge on management and reporting of Lassa fever

A higher proportion (42.6%) of respondents who were males were more likely to have a good knowledge on Lassa fever management and reporting, compared to females (34.3%), p = 0.244. Respondents who had more than 20 years of post graduation from medical school had a higher (49.4%) level of knowledge on Lassa fever management and reporting, compared to those who had less than 20 years of post graduation (33.3%), p = 0.031 (Table 7).
Table 7

Association between respondent’s characteristics and knowledge on management and reporting of Lassa fever

 

Knowledge

  

Variable

Good

Fair

χ2

p-value

Age:

    

< 40 years

29 (40.3)

43 (59.7)

  

≥ 40 years

30 (44.1)

38 (55.9)

0.211

0.386

Gender:

    

Male

55 (42.6)

89 (74.2)

  

Female

12 (34.3)

7 (24.1)

0.794

0.244

Ethnicity:

    

Yoruba

59 (39.1)

92 (60.9)

  

Igbo

4 (50.0)

4 (50.0)

  

Other

4 (80.0)

1 (20.0)

3.646

0.162

Marital status:

    

Currently married

59 (42.1)

81 (57.9)

  

Currently not married

4 (33.3)

16 (66.7)

0.658

0.281

Years of graduation:

    

> 20 years

40 (49.4)

41 (50.6)

  

≤ 20 years

25 (33.3)

50 (66.7)

4.127

0.031

Years of residency:

    

≤ 5 years

10 (41.7)

14 (58.3)

  

> 5 years

7 (31.8)

15 (68.2)

0.478

0.351

Primary health care

    

practice: Yes

25 (39.1)

39 (60.9)

  

No

10 (45.5)

12 (54.5)

0.277

0.389

Secondary health care

    

practice: Yes

45 (42.5)

61 (57.5)

  

No

2(33.3)

4 (66.7)

0.194

0.503

Tertiary health care

    

practice: Yes

38 (40.4)

56 (59.6)

  

No

1 (50.0)

1 (50.0)

0.740

0.650

Predictors of knowledge on Lassa fever management and reporting

In the multi-variate analysis, the only factor that was significantly predictive of knowledge on Lassa fever management and reporting was years of graduation. Table 8 shows that respondents who had post graduation year more than 20 years were more likely to have a good knowledge compared to those who had 20 years or lesser post graduation experience (OR = 0.48, 95% CI = 0.24–0.94).
Table 8

Logistic regression for respondent’s characteristics and knowledge on Lassa fever management and reporting

Variable

OR

95% CI

p-value

Gender: Male

0.86

0.38 – 1.96

0.72

Female

1

  

Ethnicity:

   

Yoruba

1

  

Igbo

0.65

0.15 – 2.77

0.56

Other

0.13

0.01 – 1.28

0.08

Year of graduation:

   

> 20 years

0.48

0.24 – 0.94

0.032

≤ 20 years

1

  

Discussion

This study assessed the knowledge, diagnosis, and reporting of Lassa fever by physicians in Nigeria. Specifically, nearly all respondents had practiced medicine for > 10 years. Despite this, none of the respondents had managed or reported a suspected case of Lassa fever. This was probably because Lassa fever is not one of the differential diagnoses usually considered when patients with febrile illnesses present for evaluation. Several studies on Lassa virus detection have reported that misdiagnoses are common among physicians due to the non-consideration of Lassa fever as a cause of febrile illness and the non-specific clinical signs and symptoms of a large proportion of Lassa infections, combined with the lack of familiarity of physicians with Lassa fever, suggesting that the infection can easily be misdiagnosed [1822].

However, most physicians interviewed had appropriate knowledge of Lassa fever. Thus, a disconnect between knowledge and practice as probable cases could have presented to these physicians that had been misdiagnosed leading to progression of the disease as seen in areas with low reporting of Lassa fever [2123]. It is therefore essential that physicians, especially those practicing in primary care, should be targeted in training on emerging diseases to increase their index of suspicion and protect themselves from exposure to this deadly virus. This training will help every physician, whether they have ‘good’ or ‘poor’ knowledge regarding the diagnosis, management, and reporting of Lassa fever. The training should emphasize the concept of universal precautions, which must be observed by every health care worker while interacting with every patient [2427].

Although all respondents believe the State Ministry of Health and their hospital pharmacy should stock Ribavirin, which is used for post-exposure prophylaxis by all contacts of suspected cases [24, 27], none of the physicians could state categorically that Ribavirin is available at all times in the hospitals with which they are affiliated. Also, no physician had the occasion to prescribe the drug previously. This showed the low-risk perception among these physicians of Lassa fever, implying that more efforts should be made by an appropriate authority to make Ribavirin available in all hospitals and equally inform the health care workers for easy access by contacts of suspected cases.

The limitation of this study was that only physicians present at the NMA continuous medical education conference were included. Although, we expected that the programme would require the participation of all doctors, this was not so based on the number who attended. We recognized that selection bias may have occurred as those who attended may be different in some characteristics (which may affect the outcome of the study) from those who did not attend, limiting the generalization of our study findings. However, the type of physicians who see the Lassa fever cases initially are generally primary care physicians, who work in private and public owned health care facilities. These practitioners formed about half (46.4%) of the study participants. Also, the study was cross-sectional and used a self-administered questionnaire. However, to the best of our knowledge, this is the first study to be conducted on the diagnosis and reporting of Lassa fever in the study area. This therefore serves as a baseline study to implement interventions to control possible epidemics of Lassa fever in the study area.

Conclusion

In conclusion, despite having an appropriate knowledge about Lassa fever, no suspected case has ever been diagnosed or reported by the physician participants. It is necessary to improve physician knowledge and practice on Lassa fever through continuous medical education. It is equally essential to ensure implementation of Lassa fever diagnostics and surveillance.

Declarations

Acknowledgement

The authors wished to thank the executive members of the Osun state Nigerian Medical Association and physicians that participated in this study.

Authors’ Affiliations

(1)
Department of Community Health, Faculty of Clinical Sciences, College of Health Sciences, Obafemi Awolowo University
(2)
Department of Epidemiology and Medical Statistics, University of Ibadan
(3)
Department of Maxillofacial Surgery, University of Ibadan
(4)
Department of Preventive Medicine, State Specialist Hospital, Asubiaro

References

  1. Macher AM, Wolfe MS: Historical Lassa fever reports and 30-year clinical update. Emerg Infect Dis. 2006, 12 (5): 835-837. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3374442/. doi: 10.3201/eid1205.050052View ArticlePubMedPubMed CentralGoogle Scholar
  2. Ibekwe T: Lassa fever: the challenge of curtaining a deadly disease. Pan Afr Med J. 2012, 11: 55-http://www.panafrican-med-journal.com/content/article/11/55/full/,PubMedPubMed CentralGoogle Scholar
  3. Richmond JK, Baglole DJ: assa fever: epidemiology, clinical features, and social consequences. BMJ. 2003, 327 (7426): 1271-1275. doi: http://dx.doi.org/10.1136/bmj.327.7426.1271 View ArticlePubMedPubMed CentralGoogle Scholar
  4. Lecompte E, Fichet-Calvet E, Daffis S, Koulemou K, Sylla O, Kourouma F, Dore A, Soropogui B, Aniskin V, Allali B, Kan KS, Lalis A, Koivogui L, Gunther S, Denys C, Meulen J: Mastomys natalensis and Lassa Fever, West Africa. Emerg Infect Dis. 2006, 12 (12): 1971-1974. doi: 10.3201/eid1212.060812 DOI:10.3201%2Feid1212.060812#pmc_ext.View ArticlePubMedPubMed CentralGoogle Scholar
  5. Kitching A, Addiman S, Cathcart S, Bischop L, Krahé D, Nicholas M, Coakley J, Lloyd G, Brooks T, Morgan D, Turbitt D: A fatal case of Lassa fever in London, January 2009. Euro Surveill. 2009, 14 (6): http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19117,Google Scholar
  6. Yun NE, Walker DH: Pathogenesis of Lassa fever. Viruses. 2012, 2031–2048: 4-doi: 10.3390/v4102031Google Scholar
  7. Salazar-Bravo J, Ruedas LA, Yates TL: Mammalian reservoirs of arenaviruses. Curr Top Microbiol Immunol. 2002, 262: 25-63. http://www.ncbi.nlm.nih.gov/pubmed/11987807,PubMedGoogle Scholar
  8. Lassa Fever Fact Sheet. Centers for Disease Control and Prevention. http://www.cdc.gov/ncidod/dvrd/spb/mnpages/dispages/Fact_Sheets/Lassa_Fever_Fact_Sheet.pdf,
  9. Safronetz D, Lopez JE, Sogoba N, Traore SF, Raffel SJ, Fischer ER, Ebihara H, Branco L, Garry RF, Schwan TG, Feldmann H: Detection of Lassa virus, Mali. Emerg Infect Dis. 2010, 16 (7): 1123-1126. http://wwwnc.cdc.gov/eid/article/16/7/10-0146_article,View ArticlePubMedPubMed CentralGoogle Scholar
  10. Ehichioya DU, Hass M, Ölschläger S, Becker-Ziaja B, Chukwu COO, Coker J, Nasidi A, Ogugua O, Günther S, Omilabu SA: Lassa Fever, Nigeria, 2005–2008. Emerg Infect Dis. 2010, 16 (6): 1040-1041. doi: 10.3201/eid1606.100080View ArticlePubMedPubMed CentralGoogle Scholar
  11. Flatz L, Rieger T, Merkler D, Bergthaler A, Regen T, Schedensack M, Bestmann L, Verschoor A, Kreutzfeldt M, Brück W, Hanisch U-K, Günther S, Pinschewer DD: T cell-dependence of Lassa fever pathogenesis. PLoS Pathog. 2010, 6: e1000836-doi:10.1371/journal.ppat.1000836View ArticlePubMedPubMed CentralGoogle Scholar
  12. Hensley L, Smith M, Geisbert J, Fritz E, Daddario-DiCaprio K, Larsen T, Geisbert T: Pathogenesis of Lassa fever in cynomolgus macaques. Virol J. 2011, 8: 205-http://www.virologyj.com/content/8/1/205. doi:10.1186/1743-422X-8-205View ArticlePubMedPubMed CentralGoogle Scholar
  13. Fichet-Calvet E, Rogers DJ: Risk maps of Lassa fever in West Africa. PLoS Negl Trop Dis. 2009, 3 (3): e388-doi:10.1371/journal.pntd.0000388View ArticlePubMedPubMed CentralGoogle Scholar
  14. Bonner PC, Schmidt WP, Belmain SR, Oshin B, Baglole D, Borchert M: Poor housing quality increases risk of rodent infestation and Lassa fever in refugee camps of Sierra Leone. Am J Trop Med Hyg. 2007, 77 (1): 169-175.PubMedGoogle Scholar
  15. Abdulraheem IS: Public Health importance of Lassa fever epidemiology, clinical features and current management review of literature. Afr J Clin Exp Microbiol. 2002, 3 (1): 33-37.Google Scholar
  16. Hadi CM, Goba A, Khan SH, Bangura J, Sankoh M, Koroma S, Juana B, Bah A, Coulibaly M, Bausch DG: Ribavirin for Lassa fever postexposure prophylaxis. Emerg Infect Dis. 2010, 16 (12): 2009-2010. doi: 10.3201/eid1612.100994View ArticlePubMedPubMed CentralGoogle Scholar
  17. World Health Organisation: Lassa fever in Nigeria. Global Alert and Response. http://www.who.int/csr/don/2012_04_04/en/,
  18. Haas WH, Breuer T, Pfaff G, Schmitz H, Köhler P, Asper M, Emmerich P, Drosten C, Gölnitz U, Fleischer K, Günther S: Imported Lassa fever in Germany: surveillance and management of contact persons. Clin Infect Dis. 2003, 36 (10): 1254-1258.View ArticlePubMedGoogle Scholar
  19. Grove JN, Branco LM, Boisen ML, Muncy IJ, Henderson LA, Schieffellin JS, Robinson JE, Bangura JJ, Fonnie M, Schoepp RJ, Hensley LE, Seisay A, Fair JN, Garry RF: Capacity building permitting comprehensive monitoring of a severe case of Lassa hemorrhagic fever in Sierra Leone with a positive outcome: Case Report. Virol J. 2011, 8: 314-doi:10.1186/1743-422X-8-3View ArticlePubMedPubMed CentralGoogle Scholar
  20. Amorosa V, MacNeil A, McConnell R, Patel A, Dillon KE, Hamilton K, Erickson BR, Campbell S, Knust B, Cannon D, Miller D, Manning C, Rollin PE, Nichol ST: Imported Lassa Fever, Pennsylvania, USA, 2010. Emerg Infect Dis. 2010, 16 (10): 1598-1600. http://wwwnc.cdc.gov/eid/article/16/10/10-0774_article. doi: 10.3201/eid1610.100774View ArticlePubMedPubMed CentralGoogle Scholar
  21. Ignatyev G, Steinkasserer A, Streltsova M, Atrasheuskaya A, Agafonov A, Lubitz W: Experimental study on the possibility of treatment of some hemorrhagic fevers. J Biotechnol. 2000, 83 (1–2): 67-76.View ArticlePubMedGoogle Scholar
  22. Colebunders R, Van Esbroeck M, Moreau M, Borchert M: Imported viral haemorrhagic fever with a potential for person-to-person transmission: review and recommendations for initial management of a suspected case in Belgium. Acta Clin Belg. 2002, 57 (5): 233-240.View ArticlePubMedGoogle Scholar
  23. Hugonnet S, Sax H, Pittet D: Management of viral haemorrhagic fevers in Switzerland. Euro Surveill. 2002, 7 (3): http://www.cdc.gov/vhf/lassa/,Google Scholar
  24. CDC: Lassa fever. CDC Bulletin. 2004, http://www.cdc.gov/vhf/lassa/. Accessed 10 September 2011Google Scholar
  25. Inegbenebor U, Okosun J, Inegbenebor J: Prevention of Lassa Fever in Nigeria. Trans R Soc Trop Med Hyg. 2010, 104 (1): 51-54. doi:10.1016/j.trstmh.2009.07.008View ArticlePubMedGoogle Scholar
  26. Ogbu O, Ajuluchukwu E, Uneke CJ: Lassa fever in West African sub-region: an overview. J Vector Borne Dis. 2007, 44: 1-11.PubMedGoogle Scholar
  27. McCormick JB, King IJ, Webb PA, Scribner CL, Craven RB, Johnson KM, Elliott LH, Belmont-Williams R: Lassa Fever Effective therapy with ribavirin. New Eng J Med. 1986, 314: 20-26.View ArticlePubMedGoogle Scholar
  28. Pre-publication history

    1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/14/344/prepub

Copyright

© Olowookere et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement